In my conversation with Riskreturn yesterday (post the conference); I heard and sense that the Partnership side of things will take some time (it seemed as Gerald was hinting that the terms will be much more significant and more favorable to shareholders later on.... as the Drug/Product line mature).
I am hopeful (but skeptical) that a HUGE partnership comes soon. If the 3rd parties meet Geralds terms; perhaps it can happen anyday.
ANF Diabetes is going to be very big; Geralds body language was very obvious (beaming ear to ear)....the timing of this latest funding deal (and the internal participation) ...seems to indicate something is definitely brewing.
Translation: LymPro partnership early next year (just my hunch); but I think MANF will strike gold in one of these Orphan indications (much sooner than later).
As riskreward168 quoted Gerald from yesterday's discussion, "people may offer to pay you 'x' now, but a little down the road will be willing to pay 100 times x."
I think "100 times x" would be great for the share price and the shareholders.
News 
Market Data 
Discover 
